Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines

Overview

Journal Clin Exp Metastasis

Specialty Oncology

Date 2008 May 8

PMID 18461285

Citations 176

Authors

T Blick

E Widodo

H Hugo

M Waltham

M E Lenburg

R M Neve

E W Thompson

Affiliations

Soon will be listed here.

Abstract

Epithelial mesenchymal transition (EMT) has long been associated with breast cancer cell invasiveness and evidence of EMT processes in clinical samples is growing rapidly. Genome-wide transcriptional profiling of increasingly larger numbers of human breast cancer (HBC) cell lines have confirmed the existence of a subgroup of cell lines (termed Basal B/Mesenchymal) with enhanced invasive properties and a predominantly mesenchymal gene expression signature, distinct from subgroups with predominantly luminal (termed Luminal) or mixed basal/luminal (termed Basal A) features (Neve et al Cancer Cell 2006). Studies providing molecular and cellular analyses of EMT features in these cell lines are summarised, and the expression levels of EMT-associated factors in these cell lines are analysed. Recent clinical studies supporting the presence of EMT-like changes in vivo are summarised. Human breast cancer cell lines with mesenchymal properties continue to hold out the promise of directing us towards key mechanisms at play in the metastatic dissemination of breast cancer.

Citing Articles

Triple-positive breast cancer: navigating heterogeneity and advancing multimodal therapies for improving patient outcomes.

Xie J, Yang Z, Li Z, Zhang T, Chen H, Chen X Cancer Cell Int. 2025; 25(1):77.

PMID: 40045297 PMC: 11881339. DOI: 10.1186/s12935-025-03680-7.

Anti-TNBC effects of Lappaol F by targeting epithelial-mesenchymal transition via regulation of GSK-3β/YAP/β-catenin and PI3K/AKT pathways.

Meng Q, Li Z, He X, Hu Y, Wu G, Huang J Front Pharmacol. 2025; 16:1496511.

PMID: 39989901 PMC: 11842333. DOI: 10.3389/fphar.2025.1496511.

ALDH Breast Cancer Stem Cells Exhibit a Mesenchymal-Senescent Hybrid Phenotype, with Elevated Metabolic and Migratory Activities.

Larrea Murillo L, Sugden C, Ozsvari B, Moftakhar Z, Hassan G, Sotgia F Cells. 2025; 13(24.

PMID: 39768151 PMC: 11674378. DOI: 10.3390/cells13242059.

EMT Dynamics in Lymph Node Metastasis of Oral Squamous Cell Carcinoma.

Ghantous Y, Mozalbat S, Nashef A, Abdol-Elraziq M, Sudri S, Araidy S Cancers (Basel). 2024; 16(6).

PMID: 38539520 PMC: 10968900. DOI: 10.3390/cancers16061185.

Programming temporal stiffness cues within extracellular matrix hydrogels for modelling cancer niches.

Major G, Ahn M, Cho W, Santos M, Wise J, Phillips E Mater Today Bio. 2024; 25:101004.

PMID: 38420142 PMC: 10900776. DOI: 10.1016/j.mtbio.2024.101004.

References

Lacroix M, Leclercq G . Relevance of breast cancer cell lines as models for breast tumours: an update. Breast Cancer Res Treat. 2004; 83(3):249-89. DOI: 10.1023/B:BREA.0000014042.54925.cc. View

Alves C, Rosivatz E, Schott C, Hollweck R, Becker I, Sarbia M . Slug is overexpressed in gastric carcinomas and may act synergistically with SIP1 and Snail in the down-regulation of E-cadherin. J Pathol. 2007; 211(5):507-515. DOI: 10.1002/path.2138. View

Korsching E, Packeisen J, Liedtke C, Hungermann D, Wulfing P, van Diest P . The origin of vimentin expression in invasive breast cancer: epithelial-mesenchymal transition, myoepithelial histogenesis or histogenesis from progenitor cells with bilinear differentiation potential?. J Pathol. 2005; 206(4):451-7. DOI: 10.1002/path.1797. View

Thompson E, Torri J, Sabol M, Sommers C, Byers S, Valverius E . Oncogene-induced basement membrane invasiveness in human mammary epithelial cells. Clin Exp Metastasis. 1994; 12(3):181-94. DOI: 10.1007/BF01753886. View

Shtutman M, Levina E, Ohouo P, Baig M, Roninson I . Cell adhesion molecule L1 disrupts E-cadherin-containing adherens junctions and increases scattering and motility of MCF7 breast carcinoma cells. Cancer Res. 2006; 66(23):11370-80. DOI: 10.1158/0008-5472.CAN-06-2106. View

Moody S, Perez D, Pan T, Sarkisian C, Portocarrero C, Sterner C . The transcriptional repressor Snail promotes mammary tumor recurrence. Cancer Cell. 2005; 8(3):197-209. DOI: 10.1016/j.ccr.2005.07.009. View

Kenny P, Lee G, Myers C, Neve R, Semeiks J, Spellman P . The morphologies of breast cancer cell lines in three-dimensional assays correlate with their profiles of gene expression. Mol Oncol. 2008; 1(1):84-96. PMC: 2391005. DOI: 10.1016/j.molonc.2007.02.004. View

Wu X, Chen H, Parker B, Rubin E, Zhu T, Lee J . HOXB7, a homeodomain protein, is overexpressed in breast cancer and confers epithelial-mesenchymal transition. Cancer Res. 2006; 66(19):9527-34. DOI: 10.1158/0008-5472.CAN-05-4470. View

Zajchowski D, Bartholdi M, Gong Y, Webster L, Liu H, Munishkin A . Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res. 2001; 61(13):5168-78. View

10.

Horikawa T, Yang J, Kondo S, Yoshizaki T, Joab I, Furukawa M . Twist and epithelial-mesenchymal transition are induced by the EBV oncoprotein latent membrane protein 1 and are associated with metastatic nasopharyngeal carcinoma. Cancer Res. 2007; 67(5):1970-8. DOI: 10.1158/0008-5472.CAN-06-3933. View

11.

Yang A, Fan F, Camp E, Van Buren G, Liu W, Somcio R . Chronic oxaliplatin resistance induces epithelial-to-mesenchymal transition in colorectal cancer cell lines. Clin Cancer Res. 2006; 12(14 Pt 1):4147-53. DOI: 10.1158/1078-0432.CCR-06-0038. View

12.

Galliher A, Schiemann W . Beta3 integrin and Src facilitate transforming growth factor-beta mediated induction of epithelial-mesenchymal transition in mammary epithelial cells. Breast Cancer Res. 2006; 8(4):R42. PMC: 1779461. DOI: 10.1186/bcr1524. View

13.

Blanco M, Moreno-Bueno G, Sarrio D, Locascio A, Cano A, Palacios J . Correlation of Snail expression with histological grade and lymph node status in breast carcinomas. Oncogene. 2002; 21(20):3241-6. DOI: 10.1038/sj.onc.1205416. View

14.

Ross D, Scherf U, Eisen M, Perou C, Rees C, Spellman P . Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet. 2000; 24(3):227-35. DOI: 10.1038/73432. View

15.

Vasko V, Espinosa A, Scouten W, He H, Auer H, Liyanarachchi S . Gene expression and functional evidence of epithelial-to-mesenchymal transition in papillary thyroid carcinoma invasion. Proc Natl Acad Sci U S A. 2007; 104(8):2803-8. PMC: 1815262. DOI: 10.1073/pnas.0610733104. View

16.

Yuen H, Chua C, Chan Y, Wong Y, Wang X, Chan K . Significance of TWIST and E-cadherin expression in the metastatic progression of prostatic cancer. Histopathology. 2007; 50(5):648-58. DOI: 10.1111/j.1365-2559.2007.02665.x. View

17.

Peinado H, Olmeda D, Cano A . Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?. Nat Rev Cancer. 2007; 7(6):415-28. DOI: 10.1038/nrc2131. View

18.

Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E . The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell. 2001; 7(6):1267-78. DOI: 10.1016/s1097-2765(01)00260-x. View

19.

Giunciuglio D, Culty M, Fassina G, Masiello L, Melchiori A, Paglialunga G . Invasive phenotype of MCF10A cells overexpressing c-Ha-ras and c-erbB-2 oncogenes. Int J Cancer. 1995; 63(6):815-22. DOI: 10.1002/ijc.2910630612. View

20.

Zeisberg M, Kalluri R . The role of epithelial-to-mesenchymal transition in renal fibrosis. J Mol Med (Berl). 2004; 82(3):175-81. DOI: 10.1007/s00109-003-0517-9. View